DXCM vs NFBK · P/E 63, rev $2.50B vs P/E 16, rev $6.4M
DexCom Inc (DXCM) versus Northfield Bancorp Inc (NFBK) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Northfield Bancorp Inc (NFBK) is a banks - regional company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported NFBK revenue for 2024-12-31 was $6.4M. Net income was $29.9M. Revenue was up 17.4% from 2023-12-31 to 2024-12-31. NFBK currently screens at market cap $520.9M and trailing P/E 16.1.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. NFBK currently screens at market cap $520.9M and trailing P/E 16.1.
Not investment advice. Open the DXCM and NFBK stock pages for the full models.
Not investment advice.